HENRY SCHEIN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.44 USD | +0.93% |
|
+7.06% | -3.00% |
| May. 08 | UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating | MT |
| May. 08 | Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating | MT |
Presenter SpeechErin Wilson Wright (Analysts)Hi. Good morning. Good morning, everybody. My nam...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 69.9% of net sales.
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
72.76
USD
Average target price
79.75
USD
Spread / Average Target
+9.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.00% | 9.32B | |
| -2.41% | 1.42B | |
| -4.62% | 1.39B | |
| -6.54% | 1.2B | |
| -12.55% | 910M | |
| +1.53% | 473M | |
| +3.96% | 441M | |
| -47.14% | 369M | |
| -18.14% | 359M | |
| -2.09% | 213M |
- Stock Market
- Equities
- HSIC Stock
- News Henry Schein, Inc.
- Transcript : Henry Schein, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 10